Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MAXY - Maxygen, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (76)	7/25/2001 9:25:27 PM
From: Elmer	Read Replies (1) \| Respond to of 262

Hi Nigel, Did you see this? biz.yahoo.com Toward the end it says,"With so much at stake, conflicts over gene patents are destined for the courts. Next fall, the Supreme Court is slated to hear a case that could shape future litigation over biotech patents. If upheld, Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. could make it harder for biotech companies to bring patent infringement cases against competitors that artificially alter a patented gene sequence, replacing one bit of DNA with another, without changing the proteins that gene produces." I think the result of that case will effect this stock a lot. Regards